脑脊液VEGF水平及血管生成能力作为胶质瘤患者潜在预后标志物的初步研究
该初步研究检测了19例个体的脑脊液VEGF浓度及血管生成能力,其中低级别胶质瘤8例、高级别胶质瘤6例、对照5例。结果显示高级别胶质瘤患者脑脊液VEGF浓度和微血管密度均高于低级别胶质瘤患者和对照组,而低级别胶质瘤与对照组间无统计学差异。作者认为脑脊液VEGF水平联合血管生成能力可作为胶质瘤恶性程度的生物学标志物。
要点
- 高级别胶质瘤患者脑脊液VEGF浓度高于低级别胶质瘤和对照组。
- 高级别胶质瘤脑脊液诱导的微血管密度高于低级别胶质瘤和对照组。
- 低级别胶质瘤与对照组间VEGF水平及血管生成能力无统计学差异。
核心结论
- 脑脊液VEGF水平联合血管生成能力可作为胶质瘤恶性程度的生物学标志物。
研究设计与样本
- 初步研究,获取19例个体脑脊液:低级别胶质瘤8例、高级别胶质瘤6例、对照5例。
- 脑脊液VEGF浓度采用ELISA测定,血管生成能力采用鸡胚绒毛尿囊膜(CAM)试验测定。
主要发现
- 高级别胶质瘤患者脑脊液VEGF浓度为2860 pg/mL ± 975,高于低级别胶质瘤患者的182.6 ± 37.1和对照组的47.4 ± 0.4。
- 高级别胶质瘤患者脑脊液生成的微血管密度为13.23 ± 0.6 vessels/9000μm2,高于低级别胶质瘤患者的9.3 ± 0.3和对照组的7.92 ± 0.2。
- 低级别胶质瘤患者与对照组间VEGF水平及血管生成能力均无统计学差异。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Gliomas are tumors of the central nervous system. Despite new classifications, they are still divided in low and high-grade gliomas, being the latter of greater malignancy. The degree of malignancy is directly related with the angiogenic activity in tumoral tissues. We measured VEGF concentrations and angiogenic capacity in cerebrospinal fluid (CSF) from patients with high and low-grade gliomas. The purpose of this study was to find a biomarker that contributes in the differential diagnosis and prognosis of gliomas. METHODS: CSF was obtained from 19 individuals: 8 with low-grade gliomas, 6 with high-grade gliomas and 5 controls. VEGF concentration in CSF was measured by ELISA and the angiogenic capacity was measured by chick chorioallantoic membrane (CAM) test. RESULTS: The VEGF concentration was higher in patients with high-grade gliomas, compared to patients with low-grade gliomas and controls (2860 pg/mL ± 975 vs. 182.6 ± 37.1 and 47.4 ± 0.4, respectively). On the other hand, CSF from patients with high-grade gliomas generated a higher microvascular density (MVD) than patients with low-grade gliomas and controls (13.23 ± 0.6 vessels/9000μm2 vs. 9.3 ± 0.3 and 7.92 ± 0.2, respectively). Interestingly, there was not statistical differences in both VEGF levels and angiogenic capacity in patients with low-grade gliomas and controls. CONCLUSION: Together VEGF levels and angiogenic capacity in CSF can be used as a biological marker of gliomas malignancy.
引用
- Vera S, Sinning M, Vergara M, et al. Cerebrospinal fluid VEGF levels and angiogenic capacity as potential prognostic markers in patients with gliomas: a pilot study. J Neurooncol. 2019. PMID: 31624989. doi:10.1007/s11060-019-03314-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。